Alison M. Karst

2.7k total citations · 1 hit paper
21 papers, 1.8k citations indexed

About

Alison M. Karst is a scholar working on Reproductive Medicine, Cancer Research and Oncology. According to data from OpenAlex, Alison M. Karst has authored 21 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Reproductive Medicine, 8 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Alison M. Karst's work include Ovarian cancer diagnosis and treatment (11 papers), Cancer Mechanisms and Therapy (3 papers) and Reproductive Biology and Fertility (3 papers). Alison M. Karst is often cited by papers focused on Ovarian cancer diagnosis and treatment (11 papers), Cancer Mechanisms and Therapy (3 papers) and Reproductive Biology and Fertility (3 papers). Alison M. Karst collaborates with scholars based in United States, Canada and Australia. Alison M. Karst's co-authors include Ronny Drapkin, Keren Levanon, Michelle S. Hirsch, Joyce F. Liu, Derek L. Dai, Ruth Perets, Jonathan G. Bijron, Barish B. Poole, Jin Yun Chen and Sunita R. Setlur and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Cancer Cell.

In The Last Decade

Alison M. Karst

21 papers receiving 1.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models

2013 402 citations Ruth Perets, Gregory A. Wyant et al. Cancer Cell profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Alison M. Karst	927	800	578	407	215	21	1.8k
Keren Levanon	534 0.6×	639 0.8×	329 0.6×	313 0.8×	216 1.0×	31	1.3k
Sanaz Memarzadeh	1.1k 1.1×	509 0.6×	918 1.6×	424 1.0×	82 0.4×	60	2.3k
Trevor G. Shepherd	1.1k 1.2×	249 0.3×	644 1.1×	406 1.0×	88 0.4×	64	1.8k
Mary Ellen Urick	672 0.7×	339 0.4×	227 0.4×	352 0.9×	72 0.3×	22	1.3k
Adam D. Steg	1.2k 1.3×	197 0.2×	852 1.5×	431 1.1×	65 0.3×	44	1.8k
Kirsi Hämäläinen	468 0.5×	141 0.2×	294 0.5×	123 0.3×	115 0.5×	32	1.0k
Anda Vlad	989 1.1×	401 0.5×	629 1.1×	270 0.7×	32 0.1×	53	2.0k
Jung‐Joo Choi	830 0.9×	180 0.2×	316 0.5×	508 1.2×	23 0.1×	41	1.5k
Antonella Tomassetti	843 0.9×	167 0.2×	428 0.7×	202 0.5×	29 0.1×	52	1.5k

Countries citing papers authored by Alison M. Karst

Since Specialization

Citations

This map shows the geographic impact of Alison M. Karst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison M. Karst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison M. Karst more than expected).

Fields of papers citing papers by Alison M. Karst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison M. Karst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison M. Karst. The network helps show where Alison M. Karst may publish in the future.

Co-authorship network of co-authors of Alison M. Karst

This figure shows the co-authorship network connecting the top 25 collaborators of Alison M. Karst. A scholar is included among the top collaborators of Alison M. Karst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison M. Karst. Alison M. Karst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Doberstein, Kai, et al.. (2018). Abstract PR01: Cyclin E: Targeting cell cycle dependencies in CCNE1-amplified tumors. Clinical Cancer Research. 24(15_Supplement). PR01–PR01. 1 indexed citations

Au‐Yeung, George, Walid J. Azar, Thomas J. Mitchell, et al.. (2016). Selective Targeting of Cyclin E1-Amplified High-Grade Serous Ovarian Cancer by Cyclin-Dependent Kinase 2 and AKT Inhibition. Clinical Cancer Research. 23(7). 1862–1874. 100 indexed citations

Novak, Marián, Jenny Lester, Alison M. Karst, et al.. (2015). Stathmin 1 and p16INK4A are sensitive adjunct biomarkers for serous tubal intraepithelial carcinoma. Gynecologic Oncology. 139(1). 104–111. 44 indexed citations

Hua, Guoqiang, Xin Lv, Changjiu He, et al.. (2015). YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells. Oncogene. 35(17). 2247–2265. 59 indexed citations

Dunn, Gavin P., Hiu Wing Cheung, Pankaj K. Agarwalla, et al.. (2014). In vivo multiplexed interrogation of amplified genes identifies GAB2 as an ovarian cancer oncogene. Proceedings of the National Academy of Sciences. 111(3). 1102–1107. 33 indexed citations

Davidowitz, Rachel A., Laura M. Selfors, Marcin Iwanicki, et al.. (2014). Mesenchymal gene program–expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance. Journal of Clinical Investigation. 124(6). 2611–2625. 103 indexed citations

Karst, Alison M., Natalie Vena, Azra H. Ligon, et al.. (2013). Cyclin E1 Deregulation Occurs Early in Secretory Cell Transformation to Promote Formation of Fallopian Tube–Derived High-Grade Serous Ovarian Cancers. Cancer Research. 74(4). 1141–1152. 132 indexed citations

Perets, Ruth, Gregory A. Wyant, Katherine W. Muto, et al.. (2013). Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models. Cancer Cell. 24(6). 751–765. 402 indexed citations breakdown →

Ren, Yin, Hiu Wing Cheung, Amit Agrawal, et al.. (2012). Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Oncogene ID4. Science Translational Medicine. 4(147). 147ra112–147ra112. 134 indexed citations

10.

Ren, Yin, Amit Agrawal, Jill P. Mesirov, et al.. (2012). Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Target ID4. DSpace@MIT (Massachusetts Institute of Technology). 2 indexed citations

11.

Karst, Alison M. & Ronny Drapkin. (2012). Primary culture and immortalization of human fallopian tube secretory epithelial cells. Nature Protocols. 7(9). 1755–1764. 109 indexed citations

12.

Karst, Alison M. & Ronny Drapkin. (2011). The new face of ovarian cancer modeling: better prospects for detection and treatment. F1000 Medicine Reports. 3. 22–22. 17 indexed citations

13.

Karst, Alison M., Keren Levanon, Sekhar Duraisamy, et al.. (2011). Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas. Gynecologic Oncology. 123(1). 5–12. 71 indexed citations

14.

Karst, Alison M., Keren Levanon, & Ronny Drapkin. (2011). Modeling high-grade serous ovarian carcinogenesis from the fallopian tube. Proceedings of the National Academy of Sciences. 108(18). 7547–7552. 216 indexed citations

15.

Karst, Alison M. & Ronny Drapkin. (2009). Ovarian Cancer Pathogenesis: A Model in Evolution. Journal of Oncology. 2010. 1–13. 216 indexed citations

16.

Karst, Alison M., Kai Gao, Colleen C. Nelson, & Gang Li. (2008). Nuclear factor kappa B subunit p50 promotes melanoma angiogenesis by upregulating interleukin‐6 expression. International Journal of Cancer. 124(2). 494–501. 43 indexed citations

17.

Karst, Alison M., et al.. (2006). BH3-only proteins in tumorigenesis and malignant melanoma. Cellular and Molecular Life Sciences. 64(3). 318–330. 21 indexed citations

18.

Karst, Alison M., Derek L. Dai, Jin Q. Cheng, & Gang Li. (2006). Role of p53 Up-regulated Modulator of Apoptosis and Phosphorylated Akt in Melanoma Cell Growth, Apoptosis, and Patient Survival. Cancer Research. 66(18). 9221–9226. 33 indexed citations

19.

Karst, Alison M., Derek L. Dai, Magdalena Martinka, & Gang Li. (2004). PUMA expression is significantly reduced in human cutaneous melanomas. Oncogene. 24(6). 1111–1116. 69 indexed citations

20.

Rice, Valerie Montgomery, et al.. (2000). Patient Tolerance to Recombinant Human Follicle Stimulating Hormone (r-hFSH, Gonal-F®) and Leuprolide Acetate (LA, Lupron®) Administered in Single or Separate Injections in Women Undergoing IVF; Preliminary Results. Fertility and Sterility. 74(3). S231–S231. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact